Caira F, Clémencet M C, Cherkaoui-Malki M, Dieuaide-Noubhani M, Pacot C, Van Veldhoven P P, Latruffe N
Laboratoire de Biologie Moléculaire et Cellulaire, Faculté des Sciences, Université de Bourgogne, BP400, 21011 Dijon Cedex, France.
Biochem J. 1998 Mar 15;330 ( Pt 3)(Pt 3):1361-8. doi: 10.1042/bj3301361.
After our previous report on the cloning of two cDNA species in guinea pig, both encoding the same hepatic 79 kDa multifunctional protein 1 (MFP-1) [Caira, Cherkaoui-Malki, Hoefler and Latruffe (1996) FEBS Lett. 378, 57-60], here we report the cloning of a cDNA encoding a second multifunctional peroxisomal protein (MFP-2) in guinea-pig liver. This 2356 nt cDNA encodes a protein of 735 residues (79.7 kDa) whose sequence shows 83% identity with rat MFP-2 [Dieuaide-Noubhani, Novikov, Baumgart, Vanhooren, Fransen, Goethals, Vandekerckhove, Van Veldhoven and Mannaerts (1996) Eur. J. Biochem. 240, 660-666]. In parallel, we studied the effect of ciprofibrate, a hypolipaemic agent also known as peroxisome proliferator in rodent, on the expression of MFP-1 and MFP-2 (2.6 kb) in rats and guinea pigs. By Northern blotting analysis we demonstrated that three MFP-1-related mRNA species are expressed in the guinea-pig liver. The expression of two of them (3.5 and 2.6 kb) is slightly increased by ciprofibrate, whereas the 3.0 kb MFP-1 mRNA is, unlike the rat one, strongly down-regulated in guinea pigs treated with ciprofibrate. In a similar way, the hepatic expression of the guinea-pig 2.6 kb MFP-2 mRNA is also down-regulated in guinea pigs treated with ciprofibrate. These results demonstrate (1) that in contrast with the unique 3.0 kb MFP-1 rat mRNA, at least three hepatic MFP-1-related mRNA species are co-expressed in guinea pig; and (2) that, opposed to the accepted idea of non-responsiveness of the guinea pig to ciprofibrate, this drug affects MFP-1 and MFP-2 gene expression in this species. Also, the mRNA species for acyl-CoA oxidase and thiolase, two other enzymes of the peroxisomal beta-oxidation pathway that are induced severalfold in responsive species are down-regulated in guinea pig. This paper is the first, to our knowledge, reporting the down-regulation of the expression of genes encoding enzymes involved in the peroxisomal beta-oxidation of fatty acids (MFP-1) and bile acid synthesis (MFP-2) in mammals.
在我们之前报道了豚鼠中两个编码相同肝脏79 kDa多功能蛋白1(MFP-1)的cDNA物种克隆之后[凯拉、切尔卡维-马尔基、赫夫勒和拉特吕夫(1996年)《欧洲生物化学学会联合会快报》378卷,第57 - 60页],在此我们报道了豚鼠肝脏中编码第二种多功能过氧化物酶体蛋白(MFP-2)的cDNA克隆。这个2356 nt的cDNA编码一个由735个氨基酸残基组成的蛋白质(79.7 kDa),其序列与大鼠MFP-2的序列有83%的同一性[迪厄艾德-努巴尼、诺维科夫、鲍姆加特、范霍伦、弗兰森、戈瑟尔斯、万德克尔克霍夫、范韦尔霍芬和曼纳茨(1996年)《欧洲生物化学杂志》240卷,第660 - 666页]。同时,我们研究了环丙贝特(一种在啮齿动物中也被称为过氧化物酶体增殖剂的降血脂药物)对大鼠和豚鼠中MFP-1和MFP-2(2.6 kb)表达的影响。通过Northern印迹分析,我们证明在豚鼠肝脏中表达了三种与MFP-1相关的mRNA物种。其中两种(3.5 kb和2.6 kb)的表达被环丙贝特轻微上调,而3.0 kb的MFP-1 mRNA与大鼠的不同,在用环丙贝特处理的豚鼠中被强烈下调。同样,豚鼠2.6 kb MFP-2 mRNA的肝脏表达在用环丙贝特处理的豚鼠中也被下调。这些结果表明:(1)与大鼠中唯一的3.0 kb MFP-1 mRNA不同,豚鼠中至少三种肝脏中与MFP-1相关的mRNA物种是共表达的;(2)与豚鼠对环丙贝特无反应这一公认观点相反,这种药物影响该物种中MFP-1和MFP-2基因的表达。此外,过氧化物酶体β-氧化途径的另外两种酶酰基辅酶A氧化酶和硫解酶的mRNA物种,在反应性物种中被诱导增加数倍,在豚鼠中却被下调。据我们所知,本文首次报道了哺乳动物中参与脂肪酸过氧化物酶体β-氧化(MFP-1)和胆汁酸合成(MFP-2)的酶编码基因表达的下调。